|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| McCune Albright Syndrome | |||||
| Polyostotic Fibrous Dysplasia | |||||
| Precocious Puberty | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Fibrous Dysplasia of Bone | |||||
| Fibrous Dysplasia, Polyostotic | |||||
| Puberty, Precocious | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Diseases | |||||
| Bone Diseases, Developmental | |||||
| Disease | |||||
| Endocrine System Diseases | |||||
| Gonadal Disorders | |||||
| Musculoskeletal Diseases | |||||
| Osteochondrodysplasias | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Letrozole | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Aromatase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Dental and Craniofacial Research (NIDCR) | |||||